Indication
Epilepsy
Assets addressing this indication.
Total attributable cost
$40.8B
$12,000/patient
Drug spend
$18.4B
$5,417/patient
45% of total cost is drugs
All severities (active epilepsy) · US
Indication
Assets addressing this indication.
Total attributable cost
$40.8B
$12,000/patient
Drug spend
$18.4B
$5,417/patient
45% of total cost is drugs
All severities (active epilepsy) · US
73 of 73 assets